Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Francesca Coli"'
Autor:
Francesca Coli, Hanna Schebesta
Publikováno v:
European Papers, Vol 2023 8, Iss 1, Pp 301-316 (2023)
(Series Information) European Papers - A Journal on Law and Integration, 2023 8(1), 301-316 | Article | (Table of Contents) I. Introduction. – II. The One Health approach: main conceptual features. – III. The One Health approach in EU policy and
Externí odkaz:
https://doaj.org/article/966c45dd890c49a89b1f4c02c58ce894
Autor:
Elena Muraro, Barbara Montico, Benedict Lum, Francesca Colizzi, Giorgio Giurato, Annamaria Salvati, Roberto Guerrieri, Aurora Rizzo, Elisa Comaro, Vincenzo Canzonieri, Andrea Anichini, Michele Del Vecchio, Roberta Mortarini, Massimo Milione, Alessandro Weisz, Maria Antonietta Pizzichetta, Fiona Simpson, Riccardo Dolcetti, Elisabetta Fratta, Luca Sigalotti
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAbout 50% of cutaneous melanoma (CM) patients present activating BRAF mutations that can be effectively targeted by BRAF inhibitors (BRAFi). However, 20% of CM patients exhibit intrinsic drug resistance to BRAFi, while most of the others
Externí odkaz:
https://doaj.org/article/9efcdcc70a744ed59d4d5235c051bf86
Autor:
Elisabetta Fratta, Giorgio Giurato, Roberto Guerrieri, Francesca Colizzi, Jessica Dal Col, Alessandro Weisz, Agostino Steffan, Barbara Montico
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract Macroautophagy, hereafter referred to as autophagy, represents a highly conserved catabolic process that maintains cellular homeostasis. At present, the role of autophagy in cutaneous melanoma (CM) is still controversial, since it appears to
Externí odkaz:
https://doaj.org/article/54b4e8e15f264547853795c1bcd20f91
Autor:
Barbara Montico, Giorgio Giurato, Giovanni Pecoraro, Annamaria Salvati, Alessia Covre, Francesca Colizzi, Agostino Steffan, Alessandro Weisz, Michele Maio, Luca Sigalotti, Elisabetta Fratta
Publikováno v:
Molecular Oncology, Vol 16, Iss 3, Pp 565-593 (2022)
Cutaneous melanoma (CM) is a very aggressive disease, often characterized by unresponsiveness to conventional therapies and high mortality rates worldwide. The identification of the activating BRAFV600 mutations in approximately 50% of CM patients ha
Externí odkaz:
https://doaj.org/article/6158288d892c4ad6a7f0325da3d7138b
Autor:
Carlo Furlan, Jerry Polesel, Luigi Barzan, Giovanni Franchin, Sandro Sulfaro, Salvatore Romeo, Francesca Colizzi, Aurora Rizzo, Vittorio Baggio, Vittorio Giacomarra, Angelo Paolo Dei Tos, Paolo Boscolo-Rizzo, Emanuela Vaccher, Riccardo Dolcetti, Luca Sigalotti, Elisabetta Fratta
Publikováno v:
Clinical Epigenetics, Vol 9, Iss 1, Pp 1-11 (2017)
Abstract Background Inclusion of new biomarkers to improve a personalized treatment approach for oropharyngeal squamous cell carcinoma (OPSCC) is urgently needed. Hypomethylation of the Long interspersed nucleotide element-1 (LINE-1) repetitive eleme
Externí odkaz:
https://doaj.org/article/fc167727b08d4835b8c443c76dcce816